| - GRCh37:
- Chr2:127827606
- GRCh38:
- Chr2:127070030
| BIN1 | M102V, M126V, M99V | Myopathy, centronuclear, 2 | Uncertain significance (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127808792
- GRCh38:
- Chr2:127051216
| BIN1 | G313R, G328R, G344R, G349R, G356R, G371R, G380R, G387R, G392R, G424R, G436R, G440R, G467R | Myopathy, centronuclear, 2 | Uncertain significance (Dec 2, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127816681
- GRCh38:
- Chr2:127059105
| BIN1 | S248F, S272F, S276F, S287F, S303F | Myopathy, centronuclear, 2 | Uncertain significance (Nov 14, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127808051
- GRCh38:
- Chr2:127050475
| BIN1 | Q332H, Q356H, Q371H, Q386H, Q401H, Q417H, Q422H, Q429H, Q444H, Q453H, Q460H, Q465H, Q497H, Q509H, Q513H, Q540H | Myopathy, centronuclear, 2 | Uncertain significance (Aug 30, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127828205
- GRCh38:
- Chr2:127070629
| BIN1 | K53R, K56R, K80R | Myopathy, centronuclear, 2 | Uncertain significance (Jul 24, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127806106
- GRCh38:
- Chr2:127048530
| BIN1 | P385L, P409L, P424L, P439L, P454L, P470L, P475L, P482L, P497L, P506L, P513L, P518L, P550L, P562L, P566L, P593L | Myopathy, centronuclear, 2 | Uncertain significance (Dec 16, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127819763
- GRCh38:
- Chr2:127062187
| BIN1 | N207S, N231S, N235S, N262S | Myopathy, centronuclear, 2 | Uncertain significance (Dec 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127809850
- GRCh38:
- Chr2:127052274
| BIN1 | A333D, A364D, A376D, A408D, A420D, A424D, A451D | Myopathy, centronuclear, 2 | Uncertain significance (Apr 5, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127825719-127828412
| BIN1 | | Myopathy, centronuclear, 2 | Uncertain significance (Jul 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127834182-127864519
| BIN1 | | Myopathy, centronuclear, 2 | Uncertain significance (Oct 27, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127828334
- GRCh38:
- Chr2:127070758
| BIN1 | | Myopathy, centronuclear, 2 | Uncertain significance (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127826494
- GRCh38:
- Chr2:127068918
| BIN1 | | Myopathy, centronuclear, 2 | Uncertain significance (Dec 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127809954
- GRCh38:
- Chr2:127052378
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127808458
- GRCh38:
- Chr2:127050882
| BIN1 | F359L, F375L, F387L, F314L, F380L, F402L, F423L, F471L, F329L, F455L, F498L, F290L, F344L, F411L, F418L, F467L | Myopathy, centronuclear, 2, Inborn genetic diseases | Uncertain significance (Nov 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:127816636
- GRCh38:
- Chr2:127059060
| BIN1 | P302L, P318L, P287L, P291L, P263L | Myopathy, centronuclear, 2 | Uncertain significance (Jul 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127827637
- GRCh38:
- Chr2:127070061
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Jan 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127834225
- GRCh38:
- Chr2:127076649
| BIN1 | V24I, V21I, V48I | Myopathy, centronuclear, 2 | Uncertain significance (Apr 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127815036
- GRCh38:
- Chr2:127057460
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (May 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127819740
- GRCh38:
- Chr2:127062164
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Mar 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127808752
- GRCh38:
- Chr2:127051176
| BIN1 | T341K, T357K, T369K, T437K, T393K, T400K, T449K, T453K, T480K, T362K, T384K, T405K, T326K | Myopathy, centronuclear, 2 | Uncertain significance (Mar 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127819679
- GRCh38:
- Chr2:127062103
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127819727
- GRCh38:
- Chr2:127062151
| BIN1 | H247R, H274R, H219R, H243R | Myopathy, centronuclear, 2 | Uncertain significance (Mar 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127825748
- GRCh38:
- Chr2:127068172
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127864420
- GRCh38:
- Chr2:127106844
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127816741
- GRCh38:
- Chr2:127059165
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Apr 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127815033
- GRCh38:
- Chr2:127057457
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Jun 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127819701
- GRCh38:
- Chr2:127062125
| BIN1 | A228T, A283T, A252T, A256T | Myopathy, centronuclear, 2 | Uncertain significance (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127826611
- GRCh38:
- Chr2:127069035
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Apr 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127808070
- GRCh38:
- Chr2:127050494
| BIN1 | T416S, T423S, T447S, T507S, T365S, T438S, T503S, T534S, T454S, T459S, T326S, T350S, T380S, T395S, T411S, T491S | Myopathy, centronuclear, 2 | Uncertain significance (May 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127808393
- GRCh38:
- Chr2:127050817
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Jul 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127807978
- GRCh38:
- Chr2:127050402
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Jun 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127811519
- GRCh38:
- Chr2:127053943
| BIN1 | V358M, V370M, V374M, V401M | Myopathy, centronuclear, 2 | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127827556
- GRCh38:
- Chr2:127069980
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127816654
- GRCh38:
- Chr2:127059078
| BIN1 | V296G, V312G, V257G, V281G, V285G | Myopathy, centronuclear, 2 | Uncertain significance (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127864493
- GRCh38:
- Chr2:127106917
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Apr 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127825777
- GRCh38:
- Chr2:127068201
| BIN1 | A192S, A165S | Myopathy, centronuclear, 2 | Uncertain significance (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127816724
- GRCh38:
- Chr2:127059148
| BIN1 | A289T, A234T, A262T, A273T, A258T | Myopathy, centronuclear, 2 | Uncertain significance (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127809876
- GRCh38:
- Chr2:127052300
| BIN1 | F367L, F442L, F399L, F415L, F355L, F324L, F411L | Myopathy, centronuclear, 2 | Uncertain significance (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127828317-127828323
- GRCh38:
- Chr2:127070741-127070747
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127864459
- GRCh38:
- Chr2:127106883
| BIN1 | K21Q | Myopathy, centronuclear, 2 | Uncertain significance (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127808426
- GRCh38:
- Chr2:127050850
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Sep 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127806189
- GRCh38:
- Chr2:127048613
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127821220
- GRCh38:
- Chr2:127063644
| BIN1 | R179H, R207H, R203H, R234H | Myopathy, centronuclear, 2 | Uncertain significance (Jun 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127825823
- GRCh38:
- Chr2:127068247
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Sep 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127821545
- GRCh38:
- Chr2:127063969
| BIN1 | V166E, V194E, V190E, V221E | Myopathy, centronuclear, 2 | Uncertain significance (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127806118
- GRCh38:
- Chr2:127048542
| BIN1 | T381I, T405I, T420I, T471I, T493I, T558I, T435I, T478I, T450I, T502I, T509I, T546I, T466I, T514I, T562I, T589I | Myopathy, centronuclear, 2 | Uncertain significance (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127808111
- GRCh38:
- Chr2:127050535
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Oct 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127827677
- GRCh38:
- Chr2:127070101
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Mar 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127815160
- GRCh38:
- Chr2:127057584
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Mar 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127811520
- GRCh38:
- Chr2:127053944
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Feb 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127808117
- GRCh38:
- Chr2:127050541
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Apr 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127816673
- GRCh38:
- Chr2:127059097
| BIN1 | A251T, A279T, A275T, A306T, A290T | Myopathy, centronuclear, 2 | Uncertain significance (Feb 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127819759
- GRCh38:
- Chr2:127062183
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127806129
- GRCh38:
- Chr2:127048553
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127864430
- GRCh38:
- Chr2:127106854
| BIN1 | | Myopathy, centronuclear, 2 | Uncertain significance (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127828408
- GRCh38:
- Chr2:127070832
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Jul 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127808501
- GRCh38:
- Chr2:127050925
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Sep 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127864426
- GRCh38:
- Chr2:127106850
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127811010
- GRCh38:
- Chr2:127053434
| BIN1 | W390C, W417C, W386C, W374C | Myopathy, centronuclear, 2 | Uncertain significance (Mar 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127808480
- GRCh38:
- Chr2:127050904
| BIN1 | P368fs, P380fs, P464fs, P307fs, P322fs, P352fs, P411fs, P460fs, P283fs, P373fs, P395fs, P448fs, P491fs, P337fs, P404fs, P416fs | Myopathy, centronuclear, 2 | Uncertain significance (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127827570
- GRCh38:
- Chr2:127069994
| BIN1 | | Myopathy, centronuclear, 2 | Uncertain significance (Jul 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127816608-127816609
- GRCh38:
- Chr2:127059032-127059033
| BIN1 | | Myopathy, centronuclear, 2 | Uncertain significance (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127834201
- GRCh38:
- Chr2:127076625
| BIN1 | | Myopathy, centronuclear, 2 | Uncertain significance (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127808418
- GRCh38:
- Chr2:127050842
| BIN1 | G303E, G388E, G415E, G424E, G468E, G480E, G484E, G357E, G431E, G342E, G372E, G400E, G511E, G327E, G393E, G436E | Myopathy, centronuclear, 2 | Uncertain significance (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127864515
- GRCh38:
- Chr2:127106939
| BIN1 | A2V | Myopathy, centronuclear, 2 | Uncertain significance (May 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127811512
- GRCh38:
- Chr2:127053936
| BIN1 | S360N, S372N, S376N, S403N | Myopathy, centronuclear, 2 | Uncertain significance (May 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127821138
- GRCh38:
- Chr2:127063562
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Oct 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127810986
- GRCh38:
- Chr2:127053410
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127811493
- GRCh38:
- Chr2:127053917
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Oct 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127821589
- GRCh38:
- Chr2:127064013
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127827616
- GRCh38:
- Chr2:127070040
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127815056
- GRCh38:
- Chr2:127057480
| BIN1 | P348L, P344L, P375L, P359L | Myopathy, centronuclear, 2 | Uncertain significance (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127828130-127828131
- GRCh38:
- Chr2:127070554-127070555
| BIN1 | E78L, E105L, E81L | Myopathy, centronuclear, 2 | Uncertain significance (May 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127826587
- GRCh38:
- Chr2:127069011
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127808783
- GRCh38:
- Chr2:127051207
| BIN1 | P316A, P359A, P390A, P395A, P347A, P374A, P383A, P470A, P331A, P427A, P439A, P443A, P352A | Myopathy, centronuclear, 2 | Uncertain significance (Jun 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127806189
- GRCh38:
- Chr2:127048613
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127819781
- GRCh38:
- Chr2:127062205
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127815162
- GRCh38:
- Chr2:127057586
| BIN1 | P313A, P324A, P309A, P340A | Myopathy, centronuclear, 2 | Uncertain significance (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127864491
- GRCh38:
- Chr2:127106915
| BIN1 | T10M | Myopathy, centronuclear, 2 | Uncertain significance (Jan 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127816609-127816620
- GRCh38:
- Chr2:127059033-127059044
| BIN1 | | Myopathy, centronuclear, 2 | Uncertain significance (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127826485
- GRCh38:
- Chr2:127068909
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Aug 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127809916
- GRCh38:
- Chr2:127052340
| BIN1 | S386N, S402N, S354N, S398N, S342N, S429N, S311N | Myopathy, centronuclear, 2 | Uncertain significance (Mar 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127864425
- GRCh38:
- Chr2:127106849
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127827566
- GRCh38:
- Chr2:127069990
| BIN1 | | Myopathy, centronuclear, 2 | Uncertain significance (Apr 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127827579
- GRCh38:
- Chr2:127070003
| BIN1 | D108N, D111N, D135N | Myopathy, centronuclear, 2, Inborn genetic diseases | Uncertain significance (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:127825844
- GRCh38:
- Chr2:127068268
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127811558
- GRCh38:
- Chr2:127053982
| BIN1 | A357T, A388T, A345T, A361T | Myopathy, centronuclear, 2 | Uncertain significance (Mar 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127811575
- GRCh38:
- Chr2:127053999
| BIN1 | G339E, G351E, G382E, G355E | Myopathy, centronuclear, 2 | Uncertain significance (Jan 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127826622
- GRCh38:
- Chr2:127069046
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127828391
- GRCh38:
- Chr2:127070815
| BIN1 | T32M, T29M, T56M | Inborn genetic diseases, Myopathy, centronuclear, 2 | Uncertain significance (Apr 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:127809853
- GRCh38:
- Chr2:127052277
| BIN1 | T332M, T363M, T375M, T407M, T419M, T423M, T450M | not provided, Myopathy, centronuclear, 2 | Uncertain significance (May 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:127815067
- GRCh38:
- Chr2:127057491
| BIN1 | S340R, S344R, S355R, S371R | Myopathy, centronuclear, 2 | Uncertain significance (Oct 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127809836
- GRCh38:
- Chr2:127052260
| BIN1 | A338T, A369T, A381T, A413T, A425T, A429T, A456T | Myopathy, centronuclear, 2 | Uncertain significance (Sep 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127808820
- GRCh38:
- Chr2:127051244
| BIN1 | | See cases, Myopathy, centronuclear, 2 | Conflicting interpretations of pathogenicity (Mar 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:127808826
- GRCh38:
- Chr2:127051250
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Nov 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127821608
- GRCh38:
- Chr2:127064032
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (May 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127825769
- GRCh38:
- Chr2:127068193
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Nov 17, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127828320
- GRCh38:
- Chr2:127070744
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127826618
- GRCh38:
- Chr2:127069042
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Jun 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:127827661
- GRCh38:
- Chr2:127070085
| BIN1 | | Myopathy, centronuclear, 2 | Likely benign (Jun 20, 2022) | criteria provided, single submitter |